These results suggest that HDAC inhibitors not only restore imprinted tumor suppressor genes, like CDKN1C[39], but also, as an “unselective transcription activator” increase expression of deregulated oncogenes in rhabdoid tumors. The gene discussed is CDKN1C; the disease is rhabdoid tumor.